Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More Analysis and Commentary STEVEN GROSSMAN 5/29/21 Analysis and Commentary STEVEN GROSSMAN 5/29/21 President's Budget Request: Preliminary Analysis Read More Analysis and Commentary STEVEN GROSSMAN 5/28/21 Analysis and Commentary STEVEN GROSSMAN 5/28/21 President to Release FY 22 Budget Request Today Read More Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More Older Posts
Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 6/4/21 Advocacy at a Glance STEVEN GROSSMAN 6/4/21 The Alliance applauds the President’s proposed increase of $343 million in FDA’s BA budget. The Senate Agriculture-FDA Appropriations Subcommittee set its FDA budget hearing for June 10. Read More
Analysis and Commentary STEVEN GROSSMAN 5/29/21 Analysis and Commentary STEVEN GROSSMAN 5/29/21 President's Budget Request: Preliminary Analysis Read More
Analysis and Commentary STEVEN GROSSMAN 5/28/21 Analysis and Commentary STEVEN GROSSMAN 5/28/21 President to Release FY 22 Budget Request Today Read More
Advocacy at a Glance STEVEN GROSSMAN 5/28/21 Advocacy at a Glance STEVEN GROSSMAN 5/28/21 The President’s FY 22 Budget is being released on May 28. An analysis of the FDA request will be provided to Alliance members following our internal review. Read More
Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Advocacy at a Glance STEVEN GROSSMAN 5/16/21 Hill Day with Senate staff on May 25 and 26, with Alliance members invited to participate. Read More
Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Advocacy at a Glance STEVEN GROSSMAN 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
Analysis and Commentary STEVEN GROSSMAN 1/29/21 Analysis and Commentary STEVEN GROSSMAN 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 2/14/20 Analysis and Commentary STEVEN GROSSMAN 2/14/20 The Alliance's Assessment of the President's FY 21 Budget Request Read More
Advocacy at a Glance STEVEN GROSSMAN 2/14/20 Advocacy at a Glance STEVEN GROSSMAN 2/14/20 President Proposes Small FY 21 Increase for FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Advocacy at a Glance STEVEN GROSSMAN 2/7/20 Upcoming Alliance Events Read More
Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Advocacy at a Glance STEVEN GROSSMAN 3/16/19 Hill Day Coming at the Perfect Time. Now We Need You to Participate Read More
